NCT00732680View on ClinicalTrials.gov

Benefits of the Use of Botox in the Treatment of Empty Nose Syndrome Syndrome

PHASE1/PHASE2TerminatedINTERVENTIONAL

Enrollment

9

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions

Empty Nose SyndromeAtrophic Rhinitis

Interventions

DRUG

Botulinum Toxin Type A

10 Units of Botulinum Toxin Type A injected into the dilator nasalis muscle on each side of the nose.

Trial Locations (1)

55904

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER